Synthetic data only. Never enter patient information; nothing is sent or stored. For clinicians. Not FDA cleared.

CPE-003 · GFR estimation

GFR-003: Suggest cystatin C / combined eGFR for isolated possible G3a

Suggest cystatin C / combined eGFR for isolated possible G3a. Evaluates eGFRcr 2021 at or above 45.

Active rulePriority 52Kidney engine v1.2.0

Condition

  • All of:
  • eGFRcr 2021 >= 45
  • eGFRcr 2021 < 60
  • uacr mg g < 30
  • other kidney damage marker == false
  • cystatin c mg l missing

What it reports

  • Action: Consider cystatin C for eGFRcr-cys confirmation before final isolated G3a classification, where available and clinically relevant.

Evidence

  • R1KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Disease: Improving Global Outcomes (KDIGO), 2024.Supports: CKD definition and chronicity CGA classification albuminuria confirmation risk prediction referral medication stewardship progression monitoring
  • R3eGFR Equations for Adults: 2021 CKD-EPI creatinine and creatinine-cystatin C race-free equations. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) / NIH, 2026.Supports: eGFRcr computation eGFRcr-cys computation assay standardization adult eligibility

Cases where this rule fires

Open a case to see this rule fire with real inputs, then change the values until it stops.

The Clinical Intelligence Layer — transforming fragmented clinical information into structured intelligence for clinician review and action.

Contact Biod